Tomas Bergvall

507 total citations
12 papers, 356 citations indexed

About

Tomas Bergvall is a scholar working on Toxicology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Tomas Bergvall has authored 12 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Toxicology, 5 papers in Pharmacology and 4 papers in Computational Theory and Mathematics. Recurrent topics in Tomas Bergvall's work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Drug-Induced Adverse Reactions (5 papers) and Computational Drug Discovery Methods (4 papers). Tomas Bergvall is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (10 papers), Drug-Induced Adverse Reactions (5 papers) and Computational Drug Discovery Methods (4 papers). Tomas Bergvall collaborates with scholars based in Sweden, United Kingdom and United States. Tomas Bergvall's co-authors include G. Niklas Norén, Marie Lindquist, Johan Ellenius, Ola Caster, Carrie E. Pierce, Martijn J. Schuemie, Kristina Star, David Madigan, Sarah Watson and Kristina Juhlin and has published in prestigious journals such as BioMed Research International, Journal of the American Medical Informatics Association and Drug Safety.

In The Last Decade

Tomas Bergvall

12 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Bergvall Sweden 10 236 74 68 64 57 12 356
Phil Tregunno United Kingdom 7 188 0.8× 50 0.7× 46 0.7× 51 0.8× 61 1.1× 13 269
Gianmario Candore Netherlands 9 326 1.4× 100 1.4× 106 1.6× 103 1.6× 89 1.6× 18 515
Vaishali Patadia United States 9 347 1.5× 116 1.6× 92 1.4× 95 1.5× 69 1.2× 13 525
Suzie Seabroke United Kingdom 8 216 0.9× 82 1.1× 67 1.0× 51 0.8× 46 0.8× 12 418
Alexandra Păcurariu Netherlands 12 184 0.8× 37 0.5× 105 1.5× 136 2.1× 96 1.7× 24 524
Joseph M. Tonning United States 9 196 0.8× 98 1.3× 75 1.1× 34 0.5× 48 0.8× 13 503
Carrie E. Pierce United States 8 185 0.8× 38 0.5× 53 0.8× 44 0.7× 44 0.8× 11 366
Kristina Juhlin Sweden 12 391 1.7× 150 2.0× 134 2.0× 92 1.4× 86 1.5× 17 554
Nancy Yuen United States 7 287 1.2× 102 1.4× 104 1.5× 51 0.8× 50 0.9× 9 534
Mónica Muñoz United States 14 138 0.6× 36 0.5× 23 0.3× 40 0.6× 41 0.7× 45 485

Countries citing papers authored by Tomas Bergvall

Since Specialization
Citations

This map shows the geographic impact of Tomas Bergvall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Bergvall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Bergvall more than expected).

Fields of papers citing papers by Tomas Bergvall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Bergvall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Bergvall. The network helps show where Tomas Bergvall may publish in the future.

Co-authorship network of co-authors of Tomas Bergvall

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Bergvall. A scholar is included among the top collaborators of Tomas Bergvall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Bergvall. Tomas Bergvall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Sartori, Daniele, et al.. (2020). A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance. Drug Safety. 43(8). 775–785. 17 indexed citations
3.
Gattepaille, Lucie M., et al.. (2020). Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project. Drug Safety. 43(8). 797–808. 17 indexed citations
4.
Ellenius, Johan, Simon Maskell, Tomas Bergvall, et al.. (2019). Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. Drug Safety. 42(12). 1393–1407. 59 indexed citations
5.
Star, Kristina, et al.. (2019). Paediatric safety signals identified in VigiBase: Methods and results from Uppsala Monitoring Centre. Pharmacoepidemiology and Drug Safety. 28(5). 680–689. 22 indexed citations
6.
Caster, Ola, et al.. (2017). vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real‐world use. Pharmacoepidemiology and Drug Safety. 26(8). 1006–1010. 24 indexed citations
7.
Yüksel, Mustafa, et al.. (2016). An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies. BioMed Research International. 2016. 1–18. 11 indexed citations
8.
Low, Yen, Ola Caster, Tomas Bergvall, et al.. (2015). Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome. Journal of the American Medical Informatics Association. 23(5). 968–978. 11 indexed citations
9.
Asiimwe, Alex, Andrew Bate, Fatima Bhayat, et al.. (2014). Structured Assessment for Prospective Identification of Safety Signals in Electronic Medical Records: Evaluation in the Health Improvement Network. Drug Safety. 38(1). 87–100. 18 indexed citations
10.
Yüksel, Mustafa, et al.. (2013). Demonstration of the SALUS Semantic Interoperability Framework for Case Series Characterization Studies.. 1 indexed citations
11.
Norén, G. Niklas, Tomas Bergvall, Patrick Ryan, et al.. (2013). Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System. Drug Safety. 36(S1). 107–121. 31 indexed citations
12.
Bergvall, Tomas, G. Niklas Norén, & Marie Lindquist. (2013). vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues. Drug Safety. 37(1). 65–77. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026